Firstly, a strong UK commercial operation where we are recognised as a leading provider of Hospital-initiated Medicines in emergency medicine and with innovative and differentiated products in complex neurological conditions, paediatric cardiology and opioid addiction.
Secondly, we have a fast growing and successful international business currently focused around three geographical regions where we have an established reputation for supply and where there are clear growth opportunities for our products. These are Saudi Arabia and the Gulf Co-Operation Council territory, Australia and South East Asia and Northern Europe (focused on Scandinavia).
Third, our in-house manufacturing expertise in the area of sterile injectables and oral liquids combined with our modern, efficient factory which has been approved by multiple regulatory authorities, allows us to be very competitive in the supply of our essential medicines to a wide range of countries.
We hold over 120 Marketing Authorisations and have a track record of successful new product development and commercial launches through both in-licensing and internal development. Our strength in marketing Hospital-initiated Medicines makes us an ideal partner for companies looking for a commercial partner to launch hospital products in the UK and into our key international markets.